15 October 2024
Litigation Capital Management Limited
("LCM" or the "Company")
Change of Nominated Adviser and Broker
Litigation Capital Management Limited (AIM:LIT), a leading international alternative asset manager of disputes financing solutions, announces the appointment of Cavendish Capital Markets Limited as Nominated Adviser and Joint Broker, to work alongside Joint Broker Canaccord Genuity, with immediate effect.
Enquiries
| Litigation Capital Management | c/o Tavistock PR |
| Patrick Moloney, Chief Executive Officer David Collins, Chief Financial Officer | |
| | |
| Cavendish (Nomad and Joint Broker) | Tel: 020 7523 8000 |
| Jonny Franklin-Adams and Rory Sale (Corporate Finance) Tim Redfern and Jamie Anderson (Corporate Broking) | |
| Canaccord Genuity (Joint Broker) | Tel: 020 7597 5970 |
| Bobbie Hilliam | |
| | |
| Tavistock PR | Tel: 020 7920 3150 |
| Katie Hopkins Simon Hudson | lcm@tavistock.co.uk |
NOTES TO EDITORS
Litigation Capital Management (LCM) is an alternative asset manager specialising in disputes financing solutions internationally, which operates two business models. The first is direct investments made from LCM's permanent balance sheet capital and the second is third party fund management. Under those two business models, LCM currently pursues three investment strategies: Single-case funding, Portfolio funding and Acquisitions of claims. LCM generates its revenue from both its direct investments and also performance fees through asset management.
LCM has an unparalleled track record driven by disciplined project selection and robust risk management.
Currently headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM listed on AIM in December 2018, trading under the ticker LIT.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
